ecpag.org - Cognigen Corporation - Home

Success! Domain ecpag.org was analyzed on Wednesday 16. December 2015!

DomainData.org :Cognigen Corporation - Home

Title:

Cognigen Corporation - Home
Age:

Not available
Alexa Rank:
Total Sites Linking In (Alexa):

2
Domain's IP Country:
Status Code:

OK
IP Address:

Not available
Description:
Keywords:

population, PK, modeling,, PK/PD, model,, pharmacokinetics,, pharmacodynamics,, pharmacometrics, ,, NONMEM,, NONMEM, UsersNet,, NONMEM, training,, dose-response,, exposure-response,, dose, justification,, end, of, phase, 2,, meeting,, with, FDA,, IND, preparation,, NDA, preparation,, Target, product, profile,, modeling, and, simulation,, data, assembly,, real-time, data, assembly/analysis,, RTDA,, PK, data, management,, analysis-ready, dataset,, NONMEM, dataset, assembly, ,, data, management,, data, programming,, exploratory, data, analysis,, Model-based, drug, development,, clinical, pharmacology,, quantitative, pharmacology,, East, Coast, Population, Analysis, Group,, ECPAG,, sparse, sampling,, PERSPECTIVE,, Hypertext, Mapping, Software,, Drug, development, services,, contract, research, organization,, CRO, AND, pharmacometrics, (Boolean, search),, Noncompartmental, analysis,, Ivivc,, In, vitro, –, in, vivo, correlation,, Clinical, trial, simulations,, Translational, medicine,, Preclinical, modeling,, Development, strategy,, Drug, development, consulting,, Medical, writing,, Publications

ecpag.org Whois Information:

Website Important Html Tags:

TAG
TEXT
h2
Graph Library and Standards
h2
Better understand the PBPK behind your compounds.
h3
Harness the power of pharmacometrics.
h3
News and Events
h4
Latest Topic:
h4
Latest Topic:
li
Diagnostics that can be used as part of quality control efforts,
li
Informative guides to direct model building efforts, and
li
Graphical displays of hard-won insights to tell the story of your analyses to R&D teams.
li
Identify mechanistic explanations for unexplained variances in absorption characteristics and bioavailability results and use that information to guide population PK and PD modeling and simulation efforts
li
Predict drug behavior in pediatric patient populations and perform clinical trial simulations to ensure patient safety and optimize efficacy outcomes in clinical trials while minimizing number of subjects needed.
li
Perform PBPK modeling of preclinical data to define dosing strategies for First in Human (FIH) studies
strong
Visualize -
strong
Cross Project and Co-Worker Graphical Profiles -
strong
Speed the build and ensure the quality of analysis-ready data sets.....
strong
as Data Loves Discussion!

ecpag.org IP Information:

ecpag.org Alexa Information:

Site Screenshots:

Screenshot created on Wednesday 16. December 2015

This is a screenshot of ecpag.org, created on Wednesday 16. December 2015
Click on thumb to enlarge the screenshot.

Google Ranking Screenshots: